2 strong ASX blue-chip shares rated as buys by this top fund manager

These businesses have a lot going for them.

| More on:
Two smiling work colleagues discuss an investment at their office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX blue-chip shares can be very attractive businesses to look at for opportunities, thanks to their scale advantages and other positive characteristics.

When large companies are able to earn stronger profit margins than the smaller competitors, they're more compelling investments and can grow profit more from each additional dollar of revenue.

The fund manager Wilson Asset Management has outlined two appealing, large businesses in the WAM Leaders Ltd (ASX: WLE) portfolio. This listed investment company (LIC) is focused on the ASX large-cap shares. Let's take a look at why they're opportunities.

CSL Ltd (ASX: CSL)

WAM describes CSL as a global biotechnology company that's developing plasma therapies, vaccines and rare disease treatments.

The fund manager pointed out that in July, the company was a "standout" beneficiary of investment flows into the healthcare sector, driven by the ongoing unwinding of ASX bank share positioning.

WAM said previous setbacks marked an inflection point for the company, and this has led to the company taking a "more disciplined approach to capital allocation" which the fund manager expects to unlock a meaningful cost reduction opportunity in the near-term.

The investment team did point out that tariff implications "remain opaque", but the market's tolerance is increasing as "uncertainty is priced in" with the ASX blue-chip share.

CSL benefits from industry dynamics that are largely uncorrelated to the economic cycle and has demonstrated resilience through consistent delivery, according to WAM.

WAM concluded its thoughts on the ASX biotech share giant with the following:

Considering its historic multiples, long-term growth profile, and earnings growth exceeding 10% per annum, the company is attractively valued and well positioned to benefit from renewed investor interest and performance ahead.

WiseTech Global Ltd (ASX: WTC)

The other ASX blue-chip share that WAM highlighted is WiseTech, a provider of software solutions to the global logistics services industry.

WAM noted that last month the business announced the appointment of a permanent CEO, easing concerns about leadership uncertainty and governance, according to the fund manager.

The investment team noted that strong results from US technology companies bolstered the ASX tech share, while falling US bond yields made growth stock valuations "easier to justify", which helped reduce investor concerns about high stock prices.

One of the reasons why WAM Leaders is attracted to the ASX blue-chip share was its recent completion of the e2open acquisition, earlier than the market had been expecting.

WAM said:            

The acquisition significantly expands WiseTech Global's product offerings and customer base, and is expected to increase earnings from year one.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Blue Chip Shares

2 big ASX 200 shares this fund manager rates as buys

These large businesses could be strong contenders for returns.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Blue Chip Shares

3 ASX blue-chip shares I'd buy with $3,000 right now

These big stocks have a strong market position. Here’s why they’re buys…

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

3 high-quality ASX 200 shares now trading at multi-year discounts

These shares could be dirt cheap according to analysts.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Blue Chip Shares

Where to invest $10,000 in ASX shares in December

These shares could be great picks for Aussie investors this month.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

These are the top ASX blue-chip shares I'd buy today

I believe these large stocks still have significant growth potential.

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Blue Chip Shares

3 ASX stocks I'd trust with $10,000 for the next decade

Let's see why these blue chips could be great long term picks for investors.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Blue Chip Shares

These top ASX 200 stocks could rise 25% to 60%

These shares could be cheap at current levels according to analysts.

Read more »

Two brokers analysing stocks.
Blue Chip Shares

Why are QBE shares sinking 6% today?

Let's see how the insurance giant is performing in FY 2025.

Read more »